estrone has been researched along with No-Reflow Phenomenon in 2 studies
Hydroxyestrones: Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens.
No-Reflow Phenomenon: Markedly reduced or absent REPERFUSION in an infarct zone following the removal of an obstruction or constriction of an artery.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, M | 1 |
| Mu, N | 1 |
| Ren, F | 1 |
| Sun, X | 1 |
| Li, F | 1 |
| Zhang, C | 1 |
| Yang, J | 1 |
| Grines, CL | 1 |
| White, DC | 1 |
| Schreiber, T | 1 |
2 other studies available for estrone and No-Reflow Phenomenon
| Article | Year |
|---|---|
Prospective study of effects of endogenous estrogens on myocardial no-reflow risk in postmenopausal women with acute myocardial infarction.
Topics: C-Reactive Protein; Coronary Thrombosis; Estradiol; Estrone; Female; Humans; Middle Aged; Myocardial | 2014 |
Editorial: another reason for women to avoid estrogen?
Topics: Estradiol; Estrone; Female; Hormone Replacement Therapy; Humans; Myocardial Infarction; No-Reflow Ph | 2014 |